Related Experiment Videos
HIV biological phenotype: prognosis marker for transmission, disease progression and therapy
1Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.
Journal of internal medicine·2011
High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa.
International journal of STD & AIDS·2010
The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission.
AIDS research and human retroviruses·2005
A new cell line-based neutralization assay for primary HIV type 1 isolates.
AIDS research and human retroviruses·2002
Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes.
AIDS research and human retroviruses·2002
CircRNA (circ_0008057) promotes uremic serum-mediated proliferation and migration of vascular smooth muscle cells via miR-370/PLk1 signaling pathway.
Journal of biological regulators and homeostatic agents·2021
How to consider implant-prosthetic rehabilitation in elderly patients: a narrative review.
Journal of biological regulators and homeostatic agents·2021
Anti-discoloration system: a new chlorhexidine mouthwash.
Journal of biological regulators and homeostatic agents·2021
Implant rehabilitation of edentulous jaws with predominantly monolithic zirconia compared to metal-acrylic prostheses: a 2-year retrospective clinical study.
Journal of biological regulators and homeostatic agents·2021
A simplified digital workflow for the prosthetic finishing of implant rehabilitations: a case report.
Journal of biological regulators and homeostatic agents·2021
Minimally invasive digital implant-prosthetic procedure in "all on 4" rehabilitation in patients with special needs: a three-year follow-up.
Journal of biological regulators and homeostatic agents·2021
Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.
Journal of medicinal chemistry·2026
Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.
Journal of medicinal chemistry·2026
Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.
Frontiers in aging·2026